Skip to main content

Table 3 Model-based estimates of 30-day mortality, hospital length-of-stay, time to therapeutic anticoagulation, and active bleeding, stratified by PERT presence and PERT consultation

From: Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study

 

PERT PRESENT

PERT CONSULTED

30 Day mortality

 Odds ratio

1.06

0.34

 95% Confidence Interval

0.70, 0.162

0.18, 0.61

 p-value

0.8

 < 0.001*

Hospital length-of-stay

  

 Beta

-0.19

-5.4

 95% CI

-2.5, 2.1

-8.2, -2.5

 p-value

0.9

 < 0.001*

Time to therapeutic anticoagulation

 Odds ratio

0.15

-0.25

 95% CI

-0.03, 0.33

-0.49, -0.01

 p-value

0.10

0.041*

Active bleeding

 Odds ratio

0.99

0.28

 95% CI

0.51, 1.90

0.09, 0.76

 p-value

 > 0.9

0.011*